Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 239479, 9 pages
http://dx.doi.org/10.1155/2015/239479
Research Article

Inhibition of HIF-1α Affects Autophagy Mediated Glycosylation in Oral Squamous Cell Carcinoma Cells

1Department of Pathology, Stomatology Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310006, China
2Department of Oral and Maxillofacial Surgery, Stomatology Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310006, China

Received 30 July 2015; Revised 14 October 2015; Accepted 18 October 2015

Academic Editor: George Perry

Copyright © 2015 Yi-Ning Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Zhou, L. Zhao, M. Kuang et al., “Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde?” Cancer Letters, vol. 323, no. 2, pp. 115–127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. G. L. Semenza, “Hypoxia-inducible factors in physiology and medicine,” Cell, vol. 148, no. 3, pp. 399–408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. K. Vadlapatla, A. D. Vadlapudi, and A. K. Mitra, “Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases,” Current Drug Targets, vol. 14, no. 8, pp. 919–935, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. N. M. Mazure and J. Pouysségur, “Hypoxia-induced autophagy: cell death or cell survival?” Current Opinion in Cell Biology, vol. 22, no. 2, pp. 177–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. H.-Y. Liao, G.-P. Wang, S.-H. Huang et al., “HIF-1α silencing suppresses growth of lung adenocarcinoma A549 cells through induction of apoptosis,” Molecular Medicine Reports, vol. 9, no. 3, pp. 911–915, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Welsh, R. Williams, L. Kirkpatrick, G. Paine-Murrieta, and G. Powis, “Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha,” Molecular Cancer Therapeutics, vol. 3, no. 3, pp. 233–244, 2004. View at Google Scholar · View at Scopus
  7. S. T. Palayoor, J. B. Mitchell, D. Cerna, W. DeGraff, M. John-Aryankalayil, and C. N. Coleman, “PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells,” International Journal of Cancer, vol. 123, no. 10, pp. 2430–2437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. K. Otrock, H. A. Hatoum, A. H. Awada, R. S. Ishak, and A. I. Shamseddine, “Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives,” Critical Reviews in Oncology/Hematology, vol. 70, no. 2, pp. 93–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Bassagañas, S. Carvalho, A. M. Dias et al., “Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of α2β1 integrin and E-cadherin function,” PLoS ONE, vol. 9, no. 5, Article ID e98595, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. D. J. Gill, K. M. Tham, J. Chia et al., “Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 34, pp. E3152–E3161, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Kodar, J. Izotova, K. Klaamas, B. Sergeyev, L. Järvekülg, and O. Kurtenkov, “Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients,” World Journal of Gastroenterology, vol. 19, no. 23, pp. 3573–3582, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. H.-Z. Zhang, X.-Y. Xia, F. Zhu, H. Shen, K. Song, and Z.-J. Shang, “Correlation of deregulated like-acetylglucosaminyl transferase and aberrant α-dystroglycan expression with human tongue cancer metastasis,” Journal of Oral and Maxillofacial Surgery, vol. 72, no. 6, pp. 1106–1118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. C. M. Ferrer, T. P. Lynch, V. L. Sodi et al., “O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway,” Molecular Cell, vol. 54, no. 5, pp. 820–831, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. N. S. Deen, S. J. Huang, L. Gong, T. Kwok, and R. J. Devenish, “The impact of autophagic processes on the intracellular fate of Helicobacter pylori,” Autophagy, vol. 9, no. 5, pp. 639–652, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Hamasaki, N. Furuta, A. Matsuda et al., “Autophagosomes form at ER-mitochondria contact sites,” Nature, vol. 495, no. 7441, pp. 389–393, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Zhao, G. Chen, W. Zhang et al., “Autophagy regulates hypoxia-induced osteoclastogenesis through the HIF-1α/BNIP3 signaling pathway,” Journal of Cellular Physiology, vol. 227, no. 2, pp. 639–648, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Nakashima, M. Yamanaka-Tatematsu, N. Fujita et al., “Impaired autophagy by soluble endoglin, under physiological hypoxia in early pregnant period, is involved in poor placentation in preeclampsia,” Autophagy, vol. 9, no. 3, pp. 303–316, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Notte, N. Ninane, T. Arnould, and C. Michiels, “Hypoxia counteracts taxol-induced apoptosis in MDA-MB-231 breast cancer cells: role of autophagy and JNK activation,” Cell Death and Disease, vol. 4, article e638, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. E. Hubbi, H. Hu, Kshitiz, I. Ahmed, A. Levchenko, and G. L. Semenza, “Chaperone-mediated autophagy targets hypoxia-inducible factor-1α (HIF-1α) for lysosomal degradation,” The Journal of Biological Chemistry, vol. 288, no. 15, pp. 10703–10714, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. D. A. McClain, K. A. Abuelgasim, M. Nouraie et al., “Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism,” Journal of Molecular Medicine, vol. 91, no. 1, pp. 59–67, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. H. N. Suh, Y. J. Lee, M. O. Kim, J. M. Ryu, and H. J. Han, “Glucosamine-induced Sp1 O-GlcNacylation ameliorates hypoxia-induced SGLT dysfunction in primary cultured renal proximal tubule cells,” Journal of Cellular Physiology, vol. 229, no. 10, pp. 1557–1568, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Liu, Z. Wang, S. Yu, and J. Xu, “Proteasomal degradation of O-GlcNAc transferase elevates hypoxia-induced vascular endothelial inflammatory response,” Cardiovascular Research, vol. 103, no. 1, pp. 131–139, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Higashimura, Y. Nakajima, R. Yamaji et al., “Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cells,” Archives of Biochemistry and Biophysics, vol. 509, no. 1, pp. 1–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. J. Levine and A. M. Puzio-Kuter, “The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes,” Science, vol. 330, no. 6009, pp. 1340–1344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. V. Blagosklonny, “Hypoxia, MTOR and autophagy,” Autophagy, vol. 9, no. 2, pp. 260–262, 2013. View at Publisher · View at Google Scholar